Immunization Newsbriefs
Link to Main Page
  Back Search the Site Send Your Feedbck  
Immunization Newsbriefs
Read Current Issue Online
Search Newsbriefs Archives
Subscribe to Email Online
Unsubscribe from Email Online
About NNii
Vaccine Information
Health Professionals
Policy Makers
Read Current Newsbriefs

Nabi's Quit-Smoking Vaccine Advances
Fort Lauderdale Sun-Sentinel; 3D
Singer, Glenn


Nabi Biopharmaceuticals of Boca Raton, Fla., has stated that it is on track with its plans to conduct a Phase II clinical trial of its experimental stop-smoking vaccine at three colleges in the United States. Called NicVAX, the product is in the last steps of a Phase I clinical trial in the Netherlands, with 21 smokers and nine non-smokers receiving a series of injections of the vaccine to determine its safety and effectiveness at different dosage strengths. The three trial sites will enroll a total of 63 patients, funded largely by a grant of $4 million from the National Institute on Drug Abuse.

© Copyright National Network for Immunization Information. The information contained in the National Network for Immunization Information Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances.